Phargentis SA
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Bioequivalence Study of Tiotropium Bromide Inhalation Powder (NCT05161156) | Phargentis SA | 2022-03-24 |
Track Phargentis SA automatically
Every clearance here is in the API, with alerts when new ones post.